Table 2.
Pearson product moment correlations between objective physical functioning measures, objective cognitive performance measures, and the five quality of life domain scores.
| CD4 cell count | HIV-1 viral load | Trail Making Test A | Trail Making Test B | Physical quality of life | Cognitive quality of life | Emotional quality of life | Social quality of life | Functional quality of life | |
|---|---|---|---|---|---|---|---|---|---|
| CD4 cell count | 1 | ||||||||
| HIV-1 viral load | −.34** | 1 | |||||||
| Trail Making Test A | .04 | −.05 | 1 | ||||||
| Trail Making Test B | −.02 | .07 | .40** | 1 | |||||
| Physical quality of life | .02 | −.059 | −.02 | .03 | 1 | ||||
| Cognitive quality of life | −.09 | −.07 | .16* | −.10 | .43** | 1 | |||
| Emotional quality of life | −.07 | .03 | .06 | −.07 | .57** | .47** | 1 | ||
| Social quality of life | .06 | −.07 | .02 | .16* | .07 | .17* | .16* | 1 | |
| Functional quality of life | .02 | −.04 | .09 | −.02 | .32** | .49** | .37** | .50** | 1 |
Note. Quality of life data were available for 100% of patients, complete physical functioning data (HIV-1 viral load and CD4 cell count) were available for 135 patients (79.4%), and complete cognitive performance data (Trail making Test A and B) were available for 166 patients (97.6%);
**
p< 0.01;
*
p<0.05